enVVeno Medical (NVNO) News Today → Democrats Push to Replace Dollar With Digital Coin, Control Currency. (From Monetary Gold) (Ad) Free NVNO Stock Alerts $5.08 +0.08 (+1.60%) (As of 09:44 AM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 9, 2024 | msn.comNVNO Stock Earnings: enVVeno Medical Beats EPS for Q1 2024May 8, 2024 | finance.yahoo.comenVVeno Medical Reports First Quarter 2024 Financial Results and Provides Corporate UpdateApril 24, 2024 | finance.yahoo.comenVVeno Medical Corporation (NVNO)April 24, 2024 | finance.yahoo.comPositive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve(R) Pivotal Trial to be Presented Today at the 46th Annual Charing Cross SymposiumApril 16, 2024 | finance.yahoo.comNew Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024April 11, 2024 | uk.investing.comenVVeno Medical hires new CCO to guide transitionApril 10, 2024 | finanznachrichten.deenVVeno Medical Corporation: enVVeno Medical Appoints Andrew Cormack as Its Chief Commercial OfficerApril 9, 2024 | finance.yahoo.comenVVeno Medical Appoints Andrew Cormack as Its Chief Commercial OfficerMarch 16, 2024 | insidertrades.comenVVeno Medical Corporation (NASDAQ:NVNO) CTO Hamed Alavi Sells 8,334 SharesMarch 16, 2024 | finance.yahoo.comNVNO Apr 2024 10.000 callMarch 15, 2024 | finance.yahoo.comenVVeno Medical to Participate in the Virtual Investor Lunch Break: The enVVeno OpportunityMarch 6, 2024 | finance.yahoo.comPositive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual MeetingMarch 3, 2024 | finance.yahoo.comCompanies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In GrowthFebruary 29, 2024 | finanznachrichten.deenVVeno Medical Corporation: enVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate UpdateFebruary 29, 2024 | benzinga.comRecap: enVVeno Medical Q4 EarningsFebruary 29, 2024 | finance.yahoo.comenVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate UpdateFebruary 20, 2024 | finance.yahoo.comTopline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the VENOUS2024 American Venous Forum Annual Meeting on March 6, 2024February 4, 2024 | marketbeat.comenVVeno Medical (NVNO) Scheduled to Post Quarterly Earnings on MondayenVVeno Medical (NASDAQ:NVNO) will be releasing earnings on Monday, February 5, Yahoo Finance reports.January 6, 2024 | finance.yahoo.comenVVeno Medical Corporation's (NASDAQ:NVNO) Path To ProfitabilityDecember 29, 2023 | ca.finance.yahoo.comNVNO Jan 2024 5.000 callDecember 14, 2023 | finanznachrichten.deenVVeno Medical Corporation: enVVeno Medical Posts Company Highlights and Materials from 2023 VEITH SymposiumDecember 14, 2023 | finance.yahoo.comenVVeno Medical Posts Company Highlights and Materials from 2023 VEITH SymposiumNovember 16, 2023 | finance.yahoo.comenVVeno Medical Presents Positive Preliminary Device Related Material Adverse Event (MAE) Data from the VenoValve Pivotal Trial at the 50th Annual VEITH SymposiumOctober 26, 2023 | finanznachrichten.deenVVeno Medical Corporation: enVVeno Medical Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateOctober 26, 2023 | msn.comenVVeno Medical files to sell 14.71M shares for holdersOctober 26, 2023 | msn.comenVVeno Medical reports Q3 resultsOctober 26, 2023 | finance.yahoo.comenVVeno Medical Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateOctober 12, 2023 | finance.yahoo.comenVVeno Medical to Participate at the Virtual Investor Ask the CEO ConferenceOctober 9, 2023 | msn.comenVVeno (NVNO) Plans to Expedite enVVe Development for CVIOctober 6, 2023 | finance.yahoo.comenVVeno Medical Announces Private Placement of $28 MillionOctober 6, 2023 | finance.yahoo.comenVVeno Medical Announces New Expedited Development Plan for the enVVe(R) Transcatheter Based Replacement Venous ValveOctober 6, 2023 | finance.yahoo.comenVVeno Medical Achieves Full Enrollment for VenoValve U.S. Pivotal TrialAugust 1, 2023 | finanznachrichten.deenVVeno Medical Corporation: enVVeno Medical Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateJuly 31, 2023 | finance.yahoo.comenVVeno Medical Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateJuly 19, 2023 | marketbeat.comTrading was temporarily halted for "NVNO" at 11:07 AM with a stated reason of "LULD pause."July 16, 2023 | finance.yahoo.comIs enVVeno Medical (NASDAQ:NVNO) In A Good Position To Deliver On Growth Plans?July 15, 2023 | morningstar.comenVVeno Medical Corp Ordinary SharesJuly 14, 2023 | finance.yahoo.comenVVeno Medical to Host Virtual KOL Event on July 18, 2023July 5, 2023 | finance.yahoo.comenVVeno Medical Provides Enrollment Update for Ongoing VenoValve(R) U.S. Pivotal Study and Announces Upcoming Investor and KOL EventsMay 1, 2023 | benzinga.comenVVeno Medical Q1 2023 Ended Quarter With $34.2M In CashMay 1, 2023 | finance.yahoo.comenVVeno Medical Reports First Quarter 2023 Financial Results and Provides Corporate UpdateMarch 4, 2023 | finanznachrichten.deenVVeno Medical Corporation: enVVeno Medical Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate UpdateMarch 2, 2023 | finance.yahoo.comenVVeno Medical Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate UpdateFebruary 8, 2023 | finance.yahoo.comenVVeno Medical to Present at Cowen's 43rd Annual Health Care ConferenceFebruary 5, 2023 | yahoo.comWe're Not Very Worried About enVVeno Medical's (NASDAQ:NVNO) Cash Burn RateJanuary 18, 2023 | finanznachrichten.deenVVeno Medical Corporation: enVVeno Medical Promotes Dr. Hamed Alavi to Senior Vice President and Chief Technology OfficerJanuary 18, 2023 | finance.yahoo.comenVVeno Medical Promotes Dr. Hamed Alavi to Senior Vice President and Chief Technology OfficerJanuary 11, 2023 | finance.yahoo.comJTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19thNovember 17, 2022 | finance.yahoo.comPositive 3-Year VenoValve(R) First-in-Human Data Presented at 49th Annual VEITH Symposium on Vascular and Endovascular IssuesNovember 7, 2022 | finance.yahoo.comenVVeno Medical Successfully Passes Preliminary FDA Safety Review for the VenoValve U.S. Pivotal Study Get enVVeno Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter. Email Address Democrats Push to Replace Dollar With Digital Coin, Control Currency. (Ad)Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it. This means you must act NOW before it's too late. NVNO Media Mentions By Week NVNO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVNO News Sentiment▼1.240.56▲Average Medical News Sentiment NVNO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVNO Articles This Week▼40▲NVNO Articles Average Week Get enVVeno Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SEPA News MGRM News SRTS News PDEX News HSAQ News STIM News ICCM News AMIX News LUCD News CTSO News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVNO) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold GroupDoes this make you sick?Allegiance GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldBiden to Drop BOMBSHELL June 13th?Paradigm PressForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding enVVeno Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
